Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptional profiling of mouse pancreatic tumor cells II

ABSTRACT: RNA-seq analysis of sorted WT and Kdm3a-KO 6419c5 and 6694c2 mouse pancreatic tumor cells from subcutaneously implanted mouse pancreatic tumors

ORGANISM(S): Mus musculus

PROVIDER: GSE146833 | GEO | 2020/09/10

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Transcriptional profiling of mouse pancreatic tumor cells I

Project description:RNA-seq analysis of sorted WT and Klf5/Smad4/Egfr-KO 6694c2 mouse pancreatic tumor cells from subcutaneously implanted mouse pancreatic tumors

2020-09-10 | GSE146832 | GEO

Transcriptional profiling of EPHA2-WT and EPHA2-KO pancreatic tumor cells

Project description:RNA-seq analysis of sorted EPHA2-WT and EPHA2-KO tumor cells from subcutaneously implanted mouse pancreatic tumors

2019-08-31 | GSE120208 | GEO

Transcriptional profiling of Usp22-WT and Usp22-KO pancreatic tumor cells

Project description:RNA-seq analysis of sorted Usp22-WT and Usp22-KO tumor cells from subcutaneously implanted mouse pancreatic tumors

2019-11-08 | GSE140088 | GEO

Transcriptional profiling of mouse pancreatic tumor cells III

Project description:RNA-seq analysis of sorted 6419c5 mouse pancreatic tumor cells from subcutaneously implanted mouse pancreatic tumors with or without treatment of a combination immunotherapy

2020-09-10 | GSE146834 | GEO

Epigenetic profiling of sorted tumor cells from implanted T cell low and T cell high mouse pancreatic tumors

Project description:Purpose: Use ATAC-seq strategy to characterize the differentially openned chromatin region in T cell low and high mouse pancreatic tumors in order to identify factors contributing to the differential abundance of tumor infiltrating T cells. Methods: Subcutaneously implanted T cell low and high pancreatic tumors were utilized for the preparation of ATAC-seq libraries from sorted tumor cells.

2018-04-30 | GSE109935 | GEO

Transcriptional profiling of sorted tumor cells from implanted T cell low and T cell high mouse pancreatic tumors

Project description:Purpose: Use RNA-seq strategy to characterize the differentially expressed genes in T cell low and high mouse pancreatic tumors in order to identify factors contributing to the differential abundance of tumor infiltrating T cells. Methods: Subcutaneously implanted T cell low and high pancreatic tumors were utilized for the preparation of RNA-seq libraries from sorted tumor cells.

2018-04-30 | GSE109933 | GEO

TMT-proteomics of sorted MC38+ tumor cells with high-fat diet

Project description:Obesity is a major cancer risk factor, but the underlying molecular mechanisms are not always known. In this study, we look at proteome remodeling in cancer cells with obesity, comparing tumor cells sorted from mice fed high-fat versus control diet. We conducted 10-plex TMT-proteomics on GFP+ MC38 colorectal adenocarcinoma tumor cells, sorted from subcutaneously implanted tumors 12 days after implantation. This study reveals molecular pathways that change in cancer cells with obesity that promote tumor growth.

2020-12-16 | PXD019495 | Pride

Transcriptional profiling of bulk tumor samples from implanted T cell low and T cell high mouse pancreatic tumors

2018-04-30 | GSE109971 | GEO

ChIP-seq profiling of pancreatic tumor cells

Project description:Compare epigentic features between WT and Kdm3a-KO tumor cells in two tumor cell lines (6419c5 and 6694c2) with two knockout tumor cell clones (KO1 and KO2). Although immunotherapy has revolutionized cancer care, patients with pancreatic ductal adenocarcinoma (PDA) rarely respond to these treatments, a failure that is attributed to poor infiltration and activation of T cells in the tumor microenvironment (TME). We performed an in vivo CRISPR screen and identified lysine demethylase 3A (KDM3A) as a potent epigenetic regulator of immunotherapy response in PDA. Mechanistically, KDM3A acts through Krueppel-like factor 5 (KLF5) and SMAD family member 4 (SMAD4) to regulate the expression of the epidermal growth factor receptor (EGFR). Ablation of KDM3A, KLF5, SMAD4, or EGFR in tumor cells altered the immune TME and sensitized tumors to combination immunotherapy, while treatment of established tumors with an EGFR inhibitor erlotinib prompted a dose-dependent increase in intratumoral T cells. This study defines an epigenetic-transcriptional mechanism by which tumor cells modulate their immune microenvironment and highlights the potential of EGFR inhibitors as immunotherapy sensitizers in PDA.

2020-08-27 | GSE156889 | GEO

Profiling of AKVPL vs AKVPSL derived tumor cells (Mouse)

Project description:RNA was isolated from fluorescence activated cell sorted (FACS) Lgr5-GFP+ and Lgr5-GFP- from aged matched subcutaneously implanted Apcmin/+;KrasLSL-G12D/+;VillinCre; Lgr5DTReGFP;p53KO (AKVPL) and Apcmin/+;KrasLSL-G12D/+;VillinCre; Lgr5DTReGFP;p53KO;SMAD4KO (AKVPSL) intestinal tumours. "SAMPLE_ID" sample characteristic is a sample identifier internal to Genentech. The ID of this project in Genentech's ExpressionPlot database is PRJ0009421

2017-03-29 | GSE84812 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data